Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Effectiveness of Central Oncology Navigation and the Use of an ORN

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06618274

Recruiting

Promoting Physical Activity In After-School Programs for Urban Adolescents

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Montclair NJ
Sponsor: Montclair State University

Sex: All

Age: 11 - 14

Code: NCT00301158

Recruiting

Lymphedema Surveillance Study

for
Breast Cancer, Lymphedema
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT02743858

Recruiting

Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors

for
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8,
Location: Alhambra CA, Pasadena CA, Burbank CA, Beverly Hills CA,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: Female

Age: 0+

Code: NCT06113016

Phase 2, Recruiting

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

for
Tumor, Solid, Pancreatic Cancer, Melanoma
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03454035

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Toronto, Orlando FL,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06307795

Phase 1, Recruiting

Young Adult Infusion Space Experience Satisfaction Survey

for
Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 39

Code: NCT05720546

Recruiting

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

for
Head and Neck Cancer, Relapse, Recurrent, Refractory Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06096038

Phase 1, Recruiting

Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

for
Metastatic Malignant Solid Neoplasm
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06606990

Phase 1, Recruiting

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

for
brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
Location: Bethesda MD
Sponsor: Gynecologic Oncology Group

Sex: Female

Age: 18 - 70+

Code: NCT00897455

Recruiting

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

for
Breast Cancer
Location: Santa Monica CA
Sponsor: Chap, Linnea I., M.D.

Sex: Female

Age: 18+

Code: NCT00378638

Phase 2, Recruiting

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

for
Advanced Solid Tumor
Location: Fairfax VA, Cleveland OH, Dallas TX, San Antonio TX,
Sponsor: 1ST Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05761223

Phase 1, Phase 2, Recruiting

UNC Childhood, Adolescent, and Young Adult Cancer Cohort

for
Pediatric Cancer, Cancer, Cancer Metastatic, Survivorship
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 1 - 39

Code: NCT05096923

Recruiting

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

for
Solid Tumor, Renal Cell Cancer Metastatic,
Location: Philadelphia PA, Dallas TX
Sponsor: Eutilex

Sex: All

Age: 18+

Code: NCT04903873

Phase 1, Phase 2, Recruiting

Exercise and Relaxation Intervention for Young Adult Cancer Survivors

for
Cancer
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 39

Code: NCT00801008

Recruiting

The Effects of Case Management in a Medicaid Managed Care Plan

for
Neoplasms, Heart Diseases, Adrenal Cortex Diseases
Location: Brooklyn NY
Sponsor: Metropolitan Jewish Health System

Sex: All

Age: 18+

Code: NCT00385879

Recruiting

Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma

for
Breast Abnormality
Location: Washington DC
Sponsor: Walter Reed Army Medical Center

Sex: All

Age: 18+

Code: NCT01322750

Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, NSCLC Adenocarcinoma, Cholangiocarcinoma,
Location: Boston MA, New York NY, Grand Rapids MI, San Antonio TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06723236

Phase 1, Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

for
Malignant Neoplasm
Location: Jersey City NJ, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 1+

Code: NCT02688517

Recruiting

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

for
Breast Cancer
Location: Santa Monica CA, Eureka CA
Sponsor: Dr. Susan Love Research Foundation

Sex: Female

Age: 18+

Code: NCT00671476

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial